This time the Daak will take you into CCMB's work on understanding brain receptors and challenges of counting of problems like snakebites in India to deliberating on roles of ecosystems.
mailchi.mp/e9d24a804d5a/c…@CSIR_IND
#COVID19India#COVID19#coronavirus
In light of the many reports on coronavirus variant N440K lately, we would like to bring to your attention a few things:
1. The mutant is not new. We have been seeing it in South India since last year.
@CSIR_IND@AndhraPradeshCM
(1/3)
More👇🏾
The Genome India Project offers us 10,000 genomes that represent the 4 broad linguistic groups, and regions across India incl tribal populations. They are available at the Indian Biological Data Centre at RCB, Faridabad for academics to analyze and unveil mysteries held in them.
From testing of DRDO and Dr Reddy Lab's 2-DG (2-deoxy-D-glucose) on coronavirus in cell culture at CCMB to successfully clearing the phase 3 trials, it will now be used on moderate to severe COVID-19 patients. DCGI approval has come.
Training on for doctors and academics from microbiology depts of hospitals of Warangal and #Hyderabad. They will be trained on RNA isolation and one-step RT PCR to test for #COVID19 with reagents suggested by @ICMRDELHI. More trainings with more folks to happen the next few days.
Many congratulations to Avni Blotra for securing the Royal Society for Tropical Medicine and Hygiene Early Career Grants Award 2022. She will look into toxicity of venom components that stay after partial neutralisation by the Indian polyvalent antivenom against snakebites.
Here is a fresh preprint on genome analysis of SARS-CoV2 spread in India. The results show that a distinct cluster of virus population, uncharacterized thus far, which is prevalent in India - called the Clade A3i. (1/2)
biorxiv.org/content/10.110…
3. Our main focus as a community should be on reducing the spread of coronavirus. The more it spreads, the more variants come up, the more mess we create by increasing uncertainties and fear.
So, see 👇🏾
2. Though in controlled cell culture this variant makes more copies, it does not necessarily mean that it can compete with other variants just the same way in a real life pandemic where new variants keep coming up. Our genome studies say that N440K is now diminishing
(2/3)
More👇🏾
We license the dry swab direct RT-PCR COVID19 testing method to Capital Health Services India Pvt Ltd for commercialization. Way to go for ramping up COVID19 testing across the country.
@AIC_CCMB@CSIR_IND